Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 26, 2026Current Drug Therapy

Potential Inhibitors Targeting M.tb DNA Replication, Transcription, and Translation to Combat Drug Resistance

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAvijit SenASAnusree SarkarSDSneha Dutta

Discussion

Loading...

Member takes

Overview

Review explores inhibitors of M.tb processes to improve treatment for multidrug-resistant tuberculosis, suggesting new therapies.

Key Points

  • This study aims to identify molecular targets in Mycobacterium tuberculosis for developing effective anti-TB drugs.
  • Literature review using sources like PubMed, PubChem, and ResearchGate.
  • Chemical structure visualization via ChemDraw Pro 8.0.
  • Inhibitors targeting DNA replication, transcription, and translation show significant potential for treating multidrug-resistant tuberculosis.
  • Pharmacological agents can effectively disrupt M.tb's central dogma processes.

Cite This Study

Sen et al. (2026) studied this question.

synapsesocial.com/papers/6a65a91fd3aea3239cd790edhttps://doi.org/10.2174/0115748855457904260709224742
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The challenges in combating multidrug-resistant Mycobacterium tuberculosis2024
  2. 2Halting Tuberculosis in Its Tracks: Advances and Strategies for Discovering Therapeutic Targets in <i>Mycobacterium tuberculosis</i>2026
  3. 3Progress of anti-tuberculosis drug targets and novel therapeutic strategies2025
  4. 4Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis2024 · 11 citations
  5. 5A new horizon in tuberculosis control: a review of novel drug targets, mechanisms, and advanced therapeutic strategies2026